JPMorgan Chase & Co. Sells 66,018 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)
JPMorgan Chase & Co. cut its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 5.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,155,634 shares of the biotechnology company’s stock after selling 66,018 shares during the quarter. JPMorgan Chase & Co. […]
JPMorgan Chase & Co. cut its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 5.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,155,634 shares of the biotechnology company’s stock after selling 66,018 shares during the quarter. JPMorgan Chase & Co. […]
